You are here » Home » Companies » Company Overview » Concord Drugs Ltd

Concord Drugs Ltd.

BSE: 538965 Sector: Health care
NSE: N.A. ISIN Code: INE858L01010
BSE LIVE 15:29 | 27 Apr 54.75 -1.75
(-3.10%)
OPEN

56.00

HIGH

57.00

LOW

54.15

NSE 05:30 | 01 Jan Stock Is Not Traded.
OPEN 56.00
PREVIOUS CLOSE 56.50
VOLUME 4302
52-Week high 79.45
52-Week low 46.20
P/E 16.10
Mkt Cap.(Rs cr) 39.64
Buy Price 54.75
Buy Qty 40.00
Sell Price 55.60
Sell Qty 50.00
OPEN 56.00
CLOSE 56.50
VOLUME 4302
52-Week high 79.45
52-Week low 46.20
P/E 16.10
Mkt Cap.(Rs cr) 39.64
Buy Price 54.75
Buy Qty 40.00
Sell Price 55.60
Sell Qty 50.00

Concord Drugs Ltd. (CONCORDDRUGS) - Company History

CONCORD DRUGS LIMITED is a public limited company established in 1995 is among the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small volume parenterals Dry powder ) Tissue Bio-Adhesive tablets capsules and ophthalmic preparations and Ready-to-fill Pellets.State of the art technology having dedicated manufacturing facilities for Liquid Injections Dry powder Injections and Ready-to-fill Pellets ensures the highest level of process integrity and product quality.The company started with Finished Pharmaceutical Formulations and then diversified into Ready-to-fill Pellets to provide our customers with end-to-end solution to their various pharmaceutical product needs to commercial contract drug manufacturing.The company operates a state of the art cGMP contract manufacturing Formulation-Fill-Finish facility providing comprehensive pharmaceutical development and manufacturing services for drug products.The company has two manufacturing facilities built to comply with standards stipulated by Regulatory bodies.